Risk of de novo inflammatory bowel disease with TNF-α, IL-17, IL-12, and IL-23 inhibitors in adult psoriasis: a multi-centered analysis
Archives of Dermatological Research · 20.07.2026 · 318 (1)
DOI: 10.1007/s00403-026-04705-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 20.07.2026. Verfasst von Haig Pakhchanian und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pakhchanian, H., Turchetta, G., & Yang, S. (2026). Risk of de novo inflammatory bowel disease with TNF-α, IL-17, IL-12, and IL-23 inhibitors in adult psoriasis: a multi-centered analysis. Archives of Dermatological Research, 318(1). https://doi.org/10.1007/s00403-026-04705-5
Vancouver
Pakhchanian H, Turchetta G, Yang S. Risk of de novo inflammatory bowel disease with TNF-α, IL-17, IL-12, and IL-23 inhibitors in adult psoriasis: a multi-centered analysis. Archives of Dermatological Research. 2026;318(1). doi:10.1007/s00403-026-04705-5
BibTeX
@article{Pakhchanian2026,
author = {Pakhchanian, Haig and Turchetta, Grace and Yang, Sherry},
title = {Risk of de novo inflammatory bowel disease with TNF-α, IL-17, IL-12, and IL-23 inhibitors in adult psoriasis: a multi-centered analysis},
journal = {Archives of Dermatological Research},
year = {2026},
volume = {318},
number = {1},
doi = {10.1007/s00403-026-04705-5}
}
EUVIMED